دورية
Real-World Use of Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe VWD
العنوان: | Real-World Use of Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe VWD |
---|---|
المؤلفون: | Sidonio, Robert F., Weyand, Angela C, Chrisentery-Singleton, Tammuella, Chandler, Martin, Momoh, Haduwa, Driscoll-Shempp, Priscilla, Jones, Bethany, Nieto, Natalia, Caicedo, Jorge |
المصدر: | Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p2613-2613, 1p |
مستخلص: | Background:People with von Willebrand disease (VWD) present with a spectrum of bleeding patterns and clinical symptoms, independent of subtype (Rugeri. Haematologica. 2007; Kalot. Haemophilia. 2021). In certain situations, prophylaxis may be appropriate, particularly when there is recurrent and severe bleeding (Connell, Blood Advances, 2021). There are limited real-world data on the use of recombinant von Willebrand factor (rVWF) in the United States. |
قاعدة البيانات: | Supplemental Index |
تدمد: | 00064971 15280020 |
---|---|
DOI: | 10.1182/blood-2023-174729 |